Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: A systematic review

Clinical Rheumatology

Volumn 30, Issue 2, 2011, Pages 165-171

  Mattos, Priscila ^a   Santiago, Mittermayer B ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b HOSPITAL SANTA IZABEL   (Brazil)

Author keywords

Antiphospholipid antibodies; Libman Sacks endocarditis; Systemic lupus erythematosus; Valvular heart disease

Indexed keywords

IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY;

BIBLIOGRAPHIC DATABASE; DOPPLER ECHOCARDIOGRAPHY; ENDOCARDITIS; HUMAN; IMMUNOPATHOGENESIS; LIBMAN SACKS ENDOCARDITIS; MITRAL VALVE DISEASE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE DISEASE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

ANTIBODIES, ANTIPHOSPHOLIPID; HEART VALVE DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 79954445182     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1662-5     Document Type: Review

References (42)

1. Asherson RA, Hughes GR (1989) The expanding spectrum of Libman Sacks endocarditis: the role of antiphospholipid antibodies. Clin Exp Rheumatol 7(3):225-228.
2. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ et al (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335(8705):1544-1547. (Pubitemid 20189625)
3. Hughes GR, Harris NN, Gharavi AE (1986) The anticardiolipin syndrome. J Rheumatol 13(3):486-489.
4. Shoenfeld Y (2003) Systemic antiphospholipid syndrome. Lupus 12(7):497-498. (Pubitemid 36890138)
5. Asherson RA, Cervera R (2003) Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol 25(1):61- 78.
6. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients. Arthritis Rheum 46(4):1019-1027. (Pubitemid 34303815)
7. Amoroso A, Cacciapaglia F, De CS, Battagliese A, Coppolino G, Galluzzo S et al (2006) The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement. Clin Exp Rheumatol 24(3):287-294. (Pubitemid 44151148)
8. Diaz RA, Athanassopoulos G, Nihoyannopoulos P (1993) Systemic lupus erythematosus: valvular regurgitation and its relation to anticardiolipin antibodies. Rev Med Chil 121(2):156- 161.
9. Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK et al (2006) Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 54(12):3918-3925. (Pubitemid 44955895)
10. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ et al (1990) Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 335(8705):1541-1544. (Pubitemid 20189624)
11. Lolli C, Foscoli M, Giofre R, Tarquinii M, Pasquali S, Toschi GP (1993) Cardiac anomalies in systemic lupus erythematosus: their prevalence and relation to duration, disease activity and the presence of antiphospholipid antibodies. G Ital Cardiol 23 (11):1125-1134.
12. Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM (2007) Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 120(7):636-642. (Pubitemid 46977322)
13. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM (1990) Cardiac abnormalities in systemic lupus erythematosus. association with raised anticardiolipin antibodies. Circulation 82(2):369-375. (Pubitemid 20257815)
14. Perez-Villa F, Font J, Azqueta M, Espinosa G, Pare C, Cervera R et al (2005) Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, longterm, followup study. Arthritis Rheum 53(3):460-467. (Pubitemid 40799888)
15. Cervera R, Font J, Pare C, Azqueta M, Perez-Villa F, Lopez-Soto A et al (1992) Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 51(2):156-159.
16. Metz D, Jolly D, Graciet-Richard J, Nazeyrollas P, Chabert JP, Maillier B et al (1994) Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study. Cardiology 85(2):129-136. (Pubitemid 24241084)
17. Jouhikainen T, Pohjola-Sintonen S, Stephansson E (1994) Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus 3(3):167-172. (Pubitemid 24229884)
18. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW (1990) Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 89(4):411-419.
19. Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S (1992) Cardiovascular disease in systemic lupus erythematosus. a study of 75 patients form a defined population. Med Baltim 71(4):216- 223.
20. Giunta A, Picillo U, Maione S, Migliaresi S, Valentini G, Arnese M et al (1993) Spectrum of cardiac involvement in systemic lupus erythematosus: echocardiographic, echo-Doppler observations and immunological investigation. Acta Cardiol 48(2):183-197. (Pubitemid 23183638)
21. Leszczynski P, Straburzynska-Migaj E, Korczowska I, Lacki JK, Mackiewicz S (2003) Cardiac valvular disease in patients with systemic lupus erythematosus. relationship with anticardiolipin antibodies. Clin Rheumatol 22(6):405-408. (Pubitemid 41510444)
22. Gabrielli F, Alcini E, Di Prima MA, Mazzacurati G, Masala C (1995) Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 51(2):117-126.
23. Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN (1993) A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 125(4):1123-1129. (Pubitemid 23117348)
24. Ramonda R, Doria A, Villanova C, Vaccaro E, Punzi L, Fasoli G et al (1992) Evaluation of cardiac involvement in systemic lupus erythematosus. clinical and echographic study. Rev Rhum Mal OsteÂo Artic 59(12):790-796. (Pubitemid 23029476)
25. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH (1992) Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 20(5):1127-1134.
26. Alves LJ, Hydalgo L, Rolim LF, Campagnone GZ, Aidar MT, Novaes GS et al (1997) Clinical and laboratory diagnosis of heart disease in systemic lupus erythematosus. Arq Bras Cardiol 68 (2):79-83. (Pubitemid 127512830)
27. Hojnik M, George J, Ziporen L, Shoenfeld Y (1996) Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 93(8):1579-1587. (Pubitemid 26115423)
28. Lee JL, Naguwa SM, Cheema GS, Gershwin ME (2009) Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol 36(2-3):126-130.
29. Menard GE (2008) Establishing the diagnosis of Libman-Sacks endocarditis in systemic lupus erythematosus. J Gen Intern Med 23(6):883-886.
30. Soltesz P, Szekanecz Z, Kiss E, Shoenfeld Y (2007) Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev 6 (6):379-386. (Pubitemid 46810399)
31. Asherson RA, Cervera R (1991) Antiphospholipid antibodies and the heart. lessons and pitfalls for the cardiologist. Circulation 84 (2):920-923.
32. Bouma W, Klinkenberg TJ, van der Horst IC, Wijdh-den HI, Erasmus ME, Bijl M et al (2010) Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature. J Cardiothorac Surg 5:13.
33. Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD (1989) Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 86(4):407-412. (Pubitemid 19103907)
34. Ford SE, Charrette EJ, Knight J, Pym J, Ford P (1990) A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol 17(11):1499-1503.
35. Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A et al (1996) Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5(3):196-205. (Pubitemid 26197737)
36. Crozier IG, Li E, Milne MJ, Nicholls MG (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 65(16):1145-1148. (Pubitemid 20135827)
37. Khamashta MA, Gil A, Asherson RA, Vazquez JJ, Hughes GR (1989) Antiphospholipid antibodies, valvular heart disease and systemic lupus erythematosus. Am J Med 86(5):633-634.
38. Seward JB, Khandheria BK, Oh JK, Abel MD, Hughes RW Jr, Edwards WD et al (1988) Transesophageal echocardiography: technique, anatomic correlations, implementation, and clinical applications. Mayo Clin Proc 63(7):649-680.
39. Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB (1991) Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 18(2):391-397.
40. Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y (2006) Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatol Oxf Suppl 4:iv8-iv13. (Pubitemid 44446756)
41. Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. a study of 36 necropsy patients. Am J Med 58(2):243-264.
42. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J (1988) Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319(13):817-823.